Alkermes Future Growth
Future criteria checks 0/6
Alkermes's revenue and earnings are forecast to decline at 0.7% and 12.6% per annum respectively. EPS is expected to decline by 14.7% per annum. Return on equity is forecast to be 15.9% in 3 years.
Key information
-12.6%
Earnings growth rate
-14.7%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | -0.7% |
| Future return on equity | 15.9% |
| Analyst coverage | Good |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Alkermes plc's (NASDAQ:ALKS) Low P/E No Reason For Excitement
Oct 14
Is Alkermes (NASDAQ:ALKS) A Risky Investment?
Sep 17Alkermes: Fairly Valued After Post-Earnings Bump
Jul 28Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?
Jul 26Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry
Jul 04The Bottom Fishing Club: Alkermes Has Great Value And Safety
May 17Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals
May 08Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data
Apr 09Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Apr 08Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet
Jan 26Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?
Nov 01Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point
Nov 01Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?
Jul 15There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding
Jun 07Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?
Apr 10Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?
Mar 20Alkermes upgraded to neutral at BofA on improved risk/reward outlook
Oct 14Alkermes holder Sarissa Capital says it may look to increase its stake
Oct 07Alkermes: Nothing Stands Out As Interesting
Sep 26Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?
Aug 29Alkermes initiated at neutral at Piper Sandler as company in transition
Aug 16Alkermes Q2 2022 Earnings Preview
Jul 26Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?
Jun 27Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?
May 16Alkermes: Turning The Tides Towards Profitability
Apr 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,479 | 230 | 468 | 413 | 11 |
| 12/31/2025 | 1,416 | 193 | 287 | 329 | 14 |
| 12/31/2024 | 1,507 | 328 | 334 | 399 | 14 |
| 9/30/2024 | 1,505 | 387 | 315 | 356 | N/A |
| 6/30/2024 | 1,508 | 386 | 327 | 374 | N/A |
| 3/31/2024 | 1,726 | 570 | 394 | 444 | N/A |
| 12/31/2023 | 1,663 | 519 | 353 | 401 | N/A |
| 9/30/2023 | 1,591 | 455 | 254 | 295 | N/A |
| 6/30/2023 | 1,462 | 300 | 159 | 196 | N/A |
| 3/31/2023 | 1,121 | -9 | -59 | -22 | N/A |
| 12/31/2022 | 1,112 | -33 | -17 | 21 | N/A |
| 9/30/2022 | 1,132 | -129 | 14 | 51 | N/A |
| 6/30/2022 | 1,173 | -94 | 102 | 133 | N/A |
| 3/31/2022 | 1,201 | -62 | 140 | 169 | N/A |
| 12/31/2021 | 1,174 | 76 | 73 | 102 | N/A |
| 9/30/2021 | 1,129 | -92 | 112 | 138 | N/A |
| 6/30/2021 | 1,100 | -63 | 88 | 115 | N/A |
| 3/31/2021 | 1,044 | -95 | 48 | 78 | N/A |
| 12/31/2020 | 1,039 | -111 | 41 | 83 | N/A |
| 9/30/2020 | 1,171 | -74 | -11 | 58 | N/A |
| 6/30/2020 | 1,162 | -126 | -53 | 28 | N/A |
| 3/31/2020 | 1,194 | -139 | -78 | 10 | N/A |
| 12/31/2019 | 1,171 | -197 | -19 | 72 | N/A |
| 9/30/2019 | 1,074 | -201 | 14 | 91 | N/A |
| 6/30/2019 | 1,067 | -183 | 19 | 93 | N/A |
| 3/31/2019 | 1,092 | -173 | 74 | 148 | N/A |
| 12/31/2018 | 1,094 | -139 | 30 | 99 | N/A |
| 9/30/2018 | 1,054 | -139 | 5 | 75 | N/A |
| 6/30/2018 | 1,023 | -141 | N/A | 61 | N/A |
| 3/31/2018 | 937 | -152 | N/A | 6 | N/A |
| 12/31/2017 | 903 | -158 | N/A | 19 | N/A |
| 9/30/2017 | 842 | -169 | N/A | -9 | N/A |
| 6/30/2017 | 804 | -196 | N/A | -14 | N/A |
| 3/31/2017 | 781 | -200 | N/A | -20 | N/A |
| 12/31/2016 | 746 | -208 | N/A | -64 | N/A |
| 9/30/2016 | 695 | -257 | N/A | -69 | N/A |
| 6/30/2016 | 668 | -275 | N/A | -113 | N/A |
| 3/31/2016 | 624 | -274 | N/A | -100 | N/A |
| 12/31/2015 | 628 | -227 | N/A | -40 | N/A |
| 9/30/2015 | 640 | -127 | N/A | -29 | N/A |
| 6/30/2015 | 648 | -86 | N/A | -7 | N/A |
| 3/31/2015 | 650 | -36 | N/A | 17 | N/A |
| 12/31/2014 | 619 | -30 | N/A | 11 | N/A |
| 9/30/2014 | 598 | -42 | N/A | 36 | N/A |
| 6/30/2014 | 578 | -10 | N/A | 85 | N/A |
| 3/31/2014 | 563 | -7 | N/A | 89 | N/A |
| 12/31/2013 | 596 | 21 | N/A | 148 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALKS's earnings are forecast to decline over the next 3 years (-12.6% per year).
Earnings vs Market: ALKS's earnings are forecast to decline over the next 3 years (-12.6% per year).
High Growth Earnings: ALKS's earnings are forecast to decline over the next 3 years.
Revenue vs Market: ALKS's revenue is expected to decline over the next 3 years (-0.7% per year).
High Growth Revenue: ALKS's revenue is forecast to decline over the next 3 years (-0.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALKS's Return on Equity is forecast to be low in 3 years time (15.9%).